Tacrolimus Once-Daily Formulation in the Prophylaxis of Transplant Rejection in Renal or Liver Allograft Recipients

@article{Silva2012TacrolimusOF,
  title={Tacrolimus Once-Daily Formulation in the Prophylaxis of Transplant Rejection in Renal or Liver Allograft Recipients},
  author={H. Silva},
  journal={Drugs},
  year={2012},
  volume={67},
  pages={1944-1945}
}
tacrolimus. Interestingly, (unlike standard Tacrolimus Once-Daily tacrolimus) tacrolimus OD did not show a statistiFormulation in the Prophylaxis of cally significant reduction in the incidence of biopsy Transplant Rejection in Renal or confirmed acute rejection compared with ciLiver Allograft Recipients closporin. Whether this finding is due to the openA Viewpoint by Helio Tedesco Silva Jr label design of the trial, where the experimental group is always observed more carefully, or sugDivision… Expand
Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study
  • B. Krämer, B. Charpentier, +7 authors J. Mirete
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2010
...
1
2
3
4
...

References

SHOWING 1-5 OF 5 REFERENCES
Immunosuppression: Evolution in Practice and Trends, 1994–2004
  • H. Meier‐Kriesche, S. Li, +4 authors A. Leichtman
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2005
One‐Year Results with Extended‐Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
  • H. Silva, H. Yang, +7 authors M. Roy First
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2007
A study to evaluate the safety and safety profile